06.17.24 -- Medicinal Chemist, Meet Your CDMO

In this webinar our expert panel discusses the intricacies of technology transfer, drawing from real-life case studies. Investigate critical components for success, risk assessment, and effective mitigation strategies. Learn how to optimize your timeline and enhance efficiency in your transfer processes. Click here to learn more.

Now more than ever, manufacturing capability can make or break success. To navigate the challenges, small biopharma companies must adopt these strategic approaches.

The transition of intravenous in-clinic chronic disease therapies to large volume subcutaneous injections in alternate settings has created an evolving roster of new formulations and treatment options.

Characterizing Fab and Fc-Fusion proteins and developing robust manufacturing processes can help usher them to market and provide new treatment options for diseases that are challenging to treat.

Learn how a disposable upstream and downstream platform process in antibody production can increase timelines, enhance scalability, and reduce risk in biologics manufacturing.

Monoclonal antibodies (mAbs) stand as pivotal drug products and biochemical reagents in the 21st century. Explore how mRNA-encoded antigens could revolutionize antibody discovery.

Done correctly, Process Characterization reduces the risk of manufacturing failures and regulatory delays. Examine a platform approach to Process Characterization that has been proven effective in supporting the approval of several products.

Bulk filling drug substances in traditional facilities is often a lengthy, manual process where operators are relied upon to achieve accurate filling. This method increases process risk through errors that can compromise accuracy.

Join us on June 24th and learn characteristics of CDMOs that work best with early-stage, small biotech projects and a framework to manage them for success! Content in this webinar will explore this realm from the perspectives of the various stakeholders, history lessons, and future considerations. Click here to learn more.

Learn how our parallel development service works seamlessly with our existing antibody capabilities, helping to accelerate your ADC program and reach market faster.

Learn how a bioanalytical testing partner with comprehensive solutions and unwavering commitment to quality can help you bring safe and effective drugs to market with confidence.

Advanced analytical technologies offer insights into the structural characterization and quantitation of biotherapeutics, helping to advance projects to market on time.

It is necessary to achieve a well-designed and developed potency assay as it is the only analytical technique that can demonstrate the biological mechanism of action and the link to clinical efficacy.